Ep60: Tim Mayleben - a podcast by Timmerman Report

Tim Mayleben, CEO of Esperion Therapeutics, on cholesterol-lowering meds.

Further episodes of The Long Run with Luke Timmerman

Further podcasts by Timmerman Report

Website of Timmerman Report